DrugBiological
Immunoglobulins, Intravenous clinical trials
Also written IVIG, Privigen, BAY 41-1000 and TAL-05-00004.
- studies test it
- 223
- open now
- 31
- in phase 3
- 98
- first study started
- 1990
Keep track of what changes. Save the Immunoglobulins, Intravenous studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
220 studies that test it; most in 2020 (15)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1996 | 1 |
| 1997 | 1 |
| 1999 | 1 |
| 2001 | 2 |
| 2002 | 7 |
| 2003 | 4 |
| 2004 | 6 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 14 |
| 2012 | 8 |
| 2013 | 13 |
| 2014 | 8 |
| 2015 | 13 |
| 2016 | 13 |
| 2017 | 11 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 15 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 14 |
| 2026 | 12 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 27
- Phase 2
- 88
- Phase 3
- 98
- Phase 4
- 23
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 86 · Other 137
Baxalta now part of Shire (17) · Grifols Therapeutics LLC (12) · Nihon Pharmaceutical Co., Ltd (8) · Octapharma (6) · Bio Products Laboratory (6) · Kedrion S.p.A. (5) · CSL Behring (5) · National Institute of Neurological Disorders and Stroke (NINDS) (4)
Often tested with
Tested in the same studies.
Immunoglobulin G (22) · Rituximab (9) · Hyaluronoglucosaminidase (8) · Methylprednisolone (5) · Immunoglobulins (4) · Methotrexate (3) · Cyclophosphamide (3) · Mesna (3)
Studies
Open first, then newest update. How each study uses Immunoglobulins, Intravenous is read from its arms, and is right about nine times in ten.
Testing it · 223
- A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person SyndromeNot yet recruitingPhase 3Kedrion S.p.A.NCT07552987Written as Kedrion IVIg 10%
- A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)RecruitingPhase 3Kedrion S.p.A.NCT07059000Written as Kedrion IVIG 10%
- Neonatal Outcomes on Direct Fetal Intravenous Immunoglobulin During Intrauterine Transfusion for Rhesus IsoimmunizationRecruitingPhase 2Post Graduate Institute of Medical Education and Research, ChandigarhNCT07885592Written as Intravenous immunoglobulin (IVIG)
- Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary FibrosisNot yet recruitingPhase 2University of Alabama at BirminghamNCT07674745Written as Intravenous immunoglobulin
- Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)RecruitingPhase 2CSL BehringNCT07048262Written as CSL787
- Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2Enrolling by invitationPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT05350774Written as IV immunoglobulin
- A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaRecruitingPhase 3TakedaNCT06980480Written as IGI, 10%
- A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingPhase 3Grifols Therapeutics LLCNCT07540221Written as Gamunex-C
- Stopping Strep Throat With Antibodies in Healthy Adults.Not yet recruitingPhase 1Murdoch Childrens Research InstituteNCT07864350Written as Intravenous immunoglobulin (IVIG)
- A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaRecruitingPhase 3Grifols Biologicals, LLCNCT07582432Written as Gamunex-C, 10% Injectable Solution
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingPhase 3Janssen Research & Development, LLCNCT06533098Written as Intravenous immunoglobulins (IVIG)
- Autologous Stem Cell Transplantation in Patients With Systemic SclerosisRecruitingPhase 2Paul SzabolcsNCT03630211Written as Intravenous immunoglobulin
- The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing MyopathyRecruitingPhase 2University of Alabama at BirminghamNCT06599697Written as Intravenously administered pooled human immunoglobulin (IVIG)
- Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowRecruitingPhase 2International Peace Maternity and Child Health HospitalNCT07561125Written as intravenous immunoglobulin
- Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationNot yet recruitingPhase 2Hematology department of the 920th hospitalNCT07698080Written as Intravenous Immunoglobulin
- IVIG Boya: Safety, Efficacy, and PharmacokineticsNot yet recruitingPhase 3Azidus BrasilNCT06150833Written as Boya IVIG
- IVIG Trial for the Treatment of Bronchopulmonary DysplasiaRecruitingPhase 2International Peace Maternity and Child Health HospitalNCT06925360Written as intravenous immunoglobulin
- Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisRecruitingPhase 3Argyrios TzouvelekisNCT07299695Written as Intravenous immunoglobulin (IVIG)
- V-IMMUNE: A Novel Immunoglobulin Therapy for ImmunodeficiencyRecruitingPhase 3On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.NCT06954441Written as Intravenous immunoglobulin (IVIG)
- A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RecruitingPhase 3TakedaNCT06747351Written as TAK-881
See all 223 studies that test Immunoglobulins, Intravenous →
Given in every arm · 15 — Immunoglobulins, Intravenous is usual care beside what is tested
- Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki DiseaseNot yet recruitingPhase 2/3Children's Hospital of Fudan UniversityNCT07686770Written as IVIG
- A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré SyndromeNot yet recruitingPhase 2argenxNCT07821762Written as Intravenous immunoglobulin (IVIg)
- Human Albumin Combined With Plasma Exchange for Frailty InterventionNot yet recruitingNot applicableInstitute of Hematology & Blood Diseases Hospital, ChinaNCT07836127Written as Intravenous immunoglobulin (IVIG)
- A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency DiseasesCompletedPhase 2/3TakedaNCT05755035Written as HYQVIA
- Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki DiseaseCompletedPhase 3Children's Hospital of Fudan UniversityNCT04078568Written as IVIG
- A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)WithdrawnPhase 4TakedaNCT05494593Written as Intravenous Immunoglobulin (IVIG)
- Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) PatientsTerminatedPhase 1/2Momenta Pharmaceuticals, Inc.NCT03866577Written as Intravenous immunoglobulin (IVIg)
- Transplant Antibody-Mediated Rejection: Guiding Effective TreatmentsTerminatedPhase 3Imperial College LondonNCT03994783Written as Intravenous Immunoglobulin
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With NeuroblastomaCompletedPhase 3Children's Oncology GroupNCT00033293Written as Therapeutic Immune Globulin
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)WithdrawnPhase 3Hoffmann-La RocheNCT05494619Written as Intravenous immunoglobulin therapy
- Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)CompletedPhase 2Grifols Therapeutics LLCNCT04480424Written as GAMUNEX-C
- Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki DiseaseWithdrawnPhase 3Children's Hospital of Fudan UniversityNCT04535518Written as IVIG
- A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting TransplantationCompletedPhase 1Hoffmann-La RocheNCT02586051Written as Intravenous Immunoglobulin
- A Trial of Antenatal Treatment of Alloimmune ThrombocytopeniaCompletedPhase 2/3Weill Medical College of Cornell UniversityNCT00194987Written as IVIG (Intravenous Immunoglobulin)
- Randomized Trial of IVIg With or Without Cyclophosphamide in PemphigusTerminatedPhase 2NYU Langone HealthNCT00483119Written as intravenous immunoglobulin
As the comparator · 24 — what is tested is compared with Immunoglobulins, Intravenous
- A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingPhase 3SanofiNCT06290141Written as IVIg
- A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPRecruitingPhase 3argenxNCT06920004Written as IVIg
- Efficacy of Short Course of Intravenous Dexamethasone and Intravenous Immunoglobulin Therapy in Infection-Related Secondary Hemophagocytic Lymphohistiocytosis (isHLH)Not yet recruitingPhase 3Post Graduate Institute of Medical Education and Research, ChandigarhNCT07861776Written as Intravenous Immunoglobulin (IVIg) therapy
- Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)Not yet recruitingPhase 2Beijing Tiantan HospitalNCT07806916Written as Intravenous immunoglobulin (IVIG)
- Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre SyndromeNot yet recruitingNot applicableThe First Affiliated Hospital of Zhengzhou UniversityNCT05114941Written as intravenous immunoglobulin
- Clinical Study on Strategy for Refractory Henoch-Schönlein PurpuraRecruitingNot applicableChildren's Hospital of Fudan UniversityNCT03647852Written as IVIG
- Non Inferiority KawasakI Trial With AnakinraNot yet recruitingPhase 4Meyer Children's Hospital IRCCSNCT06697431Written as Intravenous Immunoglobulins, Human
- A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG TreatmentRecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT04656184Written as Intravenous immunoglobulin
- IgIV Plus Prednisone vs High-dose Dexamethasone for ITPRecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT04968899Written as Intravenous immunoglobulins
- A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor NeuropathyActive, not recruitingPhase 3argenxNCT06742190Written as IVIG (Intravenous Immunoglobulin)
- Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney TxCompletedPhase 3Hansa Biopharma ABNCT04935177Written as IVIg
- Evaluating Efgartigimod in Patients With Guillain-Barré SyndromeWithdrawnPhase 2Chafic KaramNCT05701189Written as Intravenous Immunoglobulin (IVIg)
- Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in ChildrenCompletedPhase 3Baylor College of MedicineNCT03939637Written as IVIG
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral ImmunodeficiencyCompletedPhase 3Grifols Therapeutics LLCNCT04561115Written as Gamunex-C
- IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownPhase 2Peking University People's HospitalNCT05634824Written as intravenous immunoglobulin
- Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%CompletedPhase 3Prometic Biotherapeutics, Inc.NCT02269163Written as Immune Globulin Intravenous
- A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia PatientsCompletedPhase 3McMaster UniversityNCT01621204Written as IVIG infusion
- Etoposide in the First-line Treatment of Adult EBV-HLHStatus unknownPhase 3Beijing Friendship HospitalNCT03742115Written as IVIG
- Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised TrialCompletedPhase 3Fudan UniversityNCT02298062Written as IVIG
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)WithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00230035Written as Intravenous immunoglobulin
Showing 20 of 24.
Codes
What other systems call Immunoglobulins, Intravenous · ClinicalTrials.gg INT008547
- MeSH (NLM) D016756Immunoglobulins, IntravenousOne source ClinicalTrials.gov
- RxNorm 1426680One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016756 | Immunoglobulins, Intravenous | One source ClinicalTrials.gov |
| RxNorm | 1426680 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.